Z

ZimVie Inc
NASDAQ:ZIMV

Watchlist Manager
ZimVie Inc
NASDAQ:ZIMV
Watchlist
Price: 13.85 USD 0.65%
Market Cap: 382.3m USD
Have any thoughts about
ZimVie Inc?
Write Note

ZimVie Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ZimVie Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Z
ZimVie Inc
NASDAQ:ZIMV
Cash from Financing Activities
-$25.7m
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Financing Activities
$2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Cash from Financing Activities
$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Cash from Financing Activities
$983m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Cash from Financing Activities
-$5.6B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
-4%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Financing Activities
$70m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ZimVie Inc
Glance View

Market Cap
382.1m USD
Industry
Health Care

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

ZIMV Intrinsic Value
18.47 USD
Undervaluation 25%
Intrinsic Value
Price
Z

See Also

What is ZimVie Inc's Cash from Financing Activities?
Cash from Financing Activities
-25.7m USD

Based on the financial report for Dec 31, 2023, ZimVie Inc's Cash from Financing Activities amounts to -25.7m USD.

What is ZimVie Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
23%

Over the last year, the Cash from Financing Activities growth was -1 874%. The average annual Cash from Financing Activities growth rates for ZimVie Inc have been 18% over the past three years , 23% over the past five years .

Back to Top